home > News and Publications > Publications
Reduce Your Practice Risk When Prescribing COVID-19 Medications
Posted on: 1/29/2021

In the midst of the pandemic, information related to medications used for COVID-19 treatment is rapidly changing. This could pose significant risks, including adverse drug interactions and polypharmacy, for physicians and patients when adding COVID-19 treatments to a patient’s medication regimen.

Minimizing this risk is of utmost importance in providing safe patient care.

ISMIE Mutual* offers a new webinar to address this risk, Medication Safety Considerations During the COVID-19 Pandemic, taking place March 16 from noon to 1 p.m. The program will cover risk management strategies for COVID-19 treatments and supportive/alternative therapies, along with the latest guidance and common adverse effects. 

  • Registration is open to ISMIE policyholders, ISMS members and their staffs at no cost.
  • CME offered | Register here.

 *ISMIE Mutual is ISMS’ endorsed carrier.

View Full Site View Mobile Site